Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer

Madan, R. A., Bilusic, M., Stein, M. N., Donahue, R. N., Arlen, P. M., Karzai, F., Plimack, E., Wong, Y.-N., Geynisman, D. M., Zibelman, M., Mayer, T., Strauss, J., Chen, G., Rauckhorst, M., McMahon, S., Couvillon, A., Steinberg, S., Figg, W. D., Dahut, W. L., … Gulley, J. L. (2023). Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer. The Oncologist, 28(7), 642-e561. https://doi.org/10.1093/oncolo/oyad058
Authors:
Ravi A Madan
Marijo Bilusic
Mark N Stein
Renee N Donahue
Philip M Arlen
Fatima Karzai
Elizabeth Plimack
Yu-Ning Wong
Daniel M Geynisman
Matthew Zibelman
Tina Mayer
Julius Strauss
Gang Chen
Myrna Rauckhorst
Sheri McMahon
Anna Couvillon
Seth Steinberg
William D Figg
William L Dahut
Jeffrey Schlom
James L Gulley
Affiliated Authors:
Mark N Stein
Columbia Affiliation:
Subjects:
Advancements in Prostate Cancer Research (OpenAlex Topic)
Lipid Metabolism in Cancer Pathogenesis (OpenAlex Topic)
Long-Term Effects of Testosterone on Health (OpenAlex Topic)
Prostatic Neoplasms (MeSH)
Prostatic Neoplasms, Castration-Resistant (MeSH)
Author Keywords:
anti-androgen therapy
cancer vaccine
immunotherapy
prostate cancer
elink
Publication Type:
Article
Unique ID:
10.1093/oncolo/oyad058
PMID:
37134294
DOI:
10.1093/oncolo/oyad058
Journal:
Oncologist
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View OpenAlex Record

Record Created: